Company Filing History:
Years Active: 1994-2001
Title: Innovations of Richard Raymond Renkiewicz
Introduction
Richard Raymond Renkiewicz is an accomplished inventor based in Novi, MI (US). He holds three patents that contribute significantly to the field of pharmaceuticals and medical treatments. His work focuses on methods to inhibit connective tissue degradation, which is crucial for treating various conditions, including arthritis.
Latest Patents
One of Renkiewicz's latest patents is a method of inhibiting connective tissue degradation. This invention provides a therapeutic approach for patients suffering from conditions that lead to the degradation of connective tissue. The method involves administering a therapeutically effective amount of a compound, specifically Benzylidene-lactone derivatives of fenamates and their thiocarbonyl. This compound has shown activity as an inhibitor of IL-1 or other agonist-induced proteoglycan degradation in bovine nasal cartilage. The pharmaceutical compositions containing these compounds are designed to treat conditions that benefit from such inhibition, including arthritis.
Career Highlights
Renkiewicz has made significant contributions to the pharmaceutical industry through his work at Warner-Lambert Company. His innovative approaches and research have led to advancements in medical treatments that improve patient outcomes. His dedication to research and development has established him as a notable figure in his field.
Collaborations
Throughout his career, Renkiewicz has collaborated with several professionals, including Vijaykumar M Baragi and Diane H Boschelli. These collaborations have fostered an environment of innovation and have contributed to the success of his projects.
Conclusion
Richard Raymond Renkiewicz is a prominent inventor whose work in inhibiting connective tissue degradation has the potential to transform treatment options for patients with arthritis and other related conditions. His contributions to Warner-Lambert Company and his collaborations with fellow researchers highlight his commitment to advancing medical science.